The human epidermal growth factor receptor 2 (HER2) is an additional appealing target for CAR T cell therapy in sarcoma as overexpression of HER2 has been reported in various sarcoma subtypes including osteosarcoma, synovial sarcoma and Ewing sarcoma. This evidence concerns the gene ERBB2 and osteosarcoma.